Pacific Biosciences Of Stock Price Prediction
| PACB Stock | USD 1.62 0.17 11.72% |
Momentum 63
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.18) | EPS Estimate Current Year (0.64) | EPS Estimate Next Year (0.53) | Wall Street Target Price 2.055 | EPS Estimate Current Quarter (0.19) |
Using Pacific Biosciences hype-based prediction, you can estimate the value of Pacific Biosciences of from the perspective of Pacific Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Pacific Biosciences using Pacific Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Pacific using crowd psychology based on the activity and movement of Pacific Biosciences' stock price.
Pacific Biosciences Short Interest
A significant increase or decrease in Pacific Biosciences' short interest from the previous month could be a good indicator of investor sentiment towards Pacific. Short interest can provide insight into the potential direction of Pacific Biosciences stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.5448 | Short Percent 0.1796 | Short Ratio 4.88 | Shares Short Prior Month 39.6 M | 50 Day MA 1.2254 |
Pacific Biosciences Hype to Price Pattern
Investor biases related to Pacific Biosciences' public news can be used to forecast risks associated with an investment in Pacific. The trend in average sentiment can be used to explain how an investor holding Pacific can time the market purely based on public headlines and social activities around Pacific Biosciences of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Pacific Biosciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Pacific Biosciences.
Pacific Biosciences Implied Volatility | 1.69 |
Pacific Biosciences' implied volatility exposes the market's sentiment of Pacific Biosciences of stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pacific Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pacific Biosciences stock will not fluctuate a lot when Pacific Biosciences' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Pacific Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Pacific because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pacific Biosciences after-hype prediction price | USD 1.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Pacific contract
Based on the Rule 16, the options market is currently suggesting that Pacific Biosciences of will have an average daily up or down price movement of about 0.11% per day over the life of the 2025-09-19 option contract. With Pacific Biosciences trading at USD 1.62, that is roughly USD 0.001711 . If you think that the market is fully incorporating Pacific Biosciences' daily price movement you should consider acquiring Pacific Biosciences of options at the current volatility level of 1.69%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Pacific Biosciences Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pacific Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pacific Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Pacific Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pacific Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pacific Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pacific Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Pacific Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pacific Biosciences' historical news coverage. Pacific Biosciences' after-hype downside and upside margins for the prediction period are 0.08 and 7.12, respectively. We have considered Pacific Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pacific Biosciences is dangerous at this time. Analysis and calculation of next after-hype price of Pacific Biosciences is based on 3 months time horizon.
Pacific Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pacific Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pacific Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pacific Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.73 | 5.79 | 0.04 | 0.43 | 11 Events / Month | 6 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.62 | 1.50 | 1.96 |
|
Pacific Biosciences Hype Timeline
Pacific Biosciences is at this time traded for 1.62. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of 0.43. Pacific is forecasted to decline in value after the next headline, with the price expected to drop to 1.5. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.96%, whereas the daily expected return is at this time at 0.73%. The volatility of related hype on Pacific Biosciences is about 991.86%, with the expected price after the next announcement by competition of 2.05. About 66.0% of the company shares are owned by institutional investors. The book value of Pacific Biosciences was at this time reported as 0.31. The company has Price/Earnings (P/E) ratio of 197.88. Pacific Biosciences recorded a loss per share of 2.74. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days. Check out Pacific Biosciences Basic Forecasting Models to cross-verify your projections.Pacific Biosciences Related Hype Analysis
Having access to credible news sources related to Pacific Biosciences' direct competition is more important than ever and may enhance your ability to predict Pacific Biosciences' future price movements. Getting to know how Pacific Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pacific Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SENS | Senseonics Holdings | 0.01 | 11 per month | 3.30 | (0.04) | 6.00 | (5.26) | 29.86 | |
| BFLY | Butterfly Network | 0.00 | 0 per month | 0.00 | (0.16) | 5.24 | (4.76) | 24.19 | |
| INMD | InMode | 0.01 | 9 per month | 0.00 | (0.08) | 3.53 | (3.32) | 17.69 | |
| DXCM | DexCom Inc | 0.22 | 10 per month | 1.36 | 0.06 | 2.87 | (2.81) | 20.42 | |
| TWST | Twist Bioscience Corp | 1.30 | 11 per month | 0.00 | (0.05) | 6.04 | (7.89) | 15.74 | |
| NTLA | Intellia Therapeutics | (0.14) | 9 per month | 5.45 | 0.18 | 8.60 | (5.29) | 36.46 | |
| CRSP | Crispr Therapeutics AG | (2.08) | 11 per month | 2.78 | 0.18 | 7.09 | (4.35) | 17.92 | |
| EDIT | Editas Medicine | 5.35 | 7 per month | 4.28 | 0.24 | 13.33 | (8.00) | 30.93 |
Pacific Biosciences Additional Predictive Modules
Most predictive techniques to examine Pacific price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pacific using various technical indicators. When you analyze Pacific charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pacific Biosciences Predictive Indicators
The successful prediction of Pacific Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pacific Biosciences of, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pacific Biosciences based on analysis of Pacific Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pacific Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pacific Biosciences's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 6.59 | 9.81 | 7.04 | 6.28 | Days Of Inventory On Hand | 231.98 | 140.02 | 183.72 | 161.88 |
Story Coverage note for Pacific Biosciences
The number of cover stories for Pacific Biosciences depends on current market conditions and Pacific Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pacific Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pacific Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pacific Biosciences Short Properties
Pacific Biosciences' future price predictability will typically decrease when Pacific Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pacific Biosciences of often depends not only on the future outlook of the potential Pacific Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pacific Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 288.4 M | |
| Cash And Short Term Investments | 389.9 M |
Complementary Tools for Pacific Stock analysis
When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |